{"title":"Selected Articles from This Issue","authors":"","doi":"10.1158/1055-9965.epi-32-9-hi","DOIUrl":null,"url":null,"abstract":"Highlights| September 01 2023 Selected Articles from This Issue Author & Article Information Online ISSN: 1538-7755 Print ISSN: 1055-9965 ©2023 American Association for Cancer Research2023American Association for Cancer Research Cancer Epidemiol Biomarkers Prev (2023) 32 (9): 1125. https://doi.org/10.1158/1055-9965.EPI-32-9-HI Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Article Versions Icon Versions Version of Record September 1 2023 Citation Selected Articles from This Issue. Cancer Epidemiol Biomarkers Prev 1 September 2023; 32 (9): 1125. https://doi.org/10.1158/1055-9965.EPI-32-9-HI Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest Search Advanced Search The risk for colorectal cancer and colon polyps, the precursors to colorectal cancer, varies between people for largely unclear reasons, one of which is field cancerization. The evidence for field cancerization in the colon has been modest to date. In this study, Yu and colleagues carried out studies using methylated EVL as a marker for field cancerization in the colon and a possible risk biomarker for colon polyps. The authors found mEVL associated with a 3X increased risk for colon polyps. Results provide more support for colon field cancerization and suggest mEVL may be a novel risk marker for colorectal cancer and therapeutic target for colorectal cancer chemoprevention. Human papillomavirus (HPV) cell entry through host cell surface receptors could correlate with infectivity and may play a role in cervical precancer progression. It has been shown that heparan sulfate proteoglycans (HSPG), specifically the syndecan and glypican gene families are... You do not currently have access to this content.","PeriodicalId":9488,"journal":{"name":"Cancer Epidemiology, Biomarkers & Prevention","volume":"23 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Epidemiology, Biomarkers & Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1055-9965.epi-32-9-hi","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
本期精选文章
亮点| 2023年9月1日本刊文章精选作者与文章信息在线ISSN: 1538-7755印刷ISSN: 1055-9965©2023美国癌症研究协会2023美国癌症研究协会癌症流行病学生物标志物Prev(2023) 32(9): 1125。https://doi.org/10.1158/1055-9965.EPI-32-9-HI查看图标查看文章内容图表和表格视频音频补充数据同行评审共享图标共享Facebook Twitter LinkedIn电子邮件工具图标工具获得权限引用图标引用搜索网站文章版本图标版本记录版本2023年9月1日引用本问题选定的文章。癌症流行病学生物标志物20123年9月1日;32(9): 1125。https://doi.org/10.1158/1055-9965.EPI-32-9-HI下载引文文件:Ris (Zotero)参考文献管理器EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex工具栏搜索搜索下拉菜单工具栏搜索搜索输入搜索输入自动建议搜索高级搜索结直肠癌和结肠息肉(结直肠癌的前兆)的风险在很大程度上因不明原因而有所不同,其中之一是领域癌变。到目前为止,结肠野地癌变的证据还不多。在这项研究中,Yu及其同事将甲基化EVL作为结肠肿瘤的标志物和结肠息肉的可能风险生物标志物进行了研究。作者发现,mEVL与结肠息肉风险增加3倍有关。结果为结直肠野区癌变提供了更多的支持,提示mEVL可能是结直肠癌新的危险标志物和结直肠癌化学预防的治疗靶点。人乳头瘤病毒(HPV)通过宿主细胞表面受体进入细胞可能与感染性相关,并可能在宫颈癌前期进展中发挥作用。研究表明,硫酸肝素蛋白聚糖(HSPG),特别是syndecan和glypican基因家族是一种有效的基因。您目前没有访问此内容的权限。
本文章由计算机程序翻译,如有差异,请以英文原文为准。